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HypoxiaMuscle form of lactate dehydrogenase (M-LDH), a minor LDH form in cardiomyocytes, physically interacts
with ATP-sensitive K+ (KATP) channel-forming subunits. Here, we have shown that expression of 193gly-M-
LDH, an inactive mutant of M-LDH, inhibit regulation of the KATP channels activity by LDH substrates in
embryonic rat heart H9C2 cells. In cells expressing 193gly-M-LDH chemical hypoxia has failed to activate KATP
channels. The similar results were obtained in H9C2 cells expressing Kir6.2AFA, a mutant form of Kir6.2 with
largely decreased K+ conductance. Kir6.2AFA has slightly, but signiﬁcantly, reduced cellular survival under
chemical hypoxia while the deleterious effect of 193gly-M-LDH was signiﬁcantly more pronounced. The
levels of total and subsarcolemmal ATP in H9C2 cells were not affected by Kir6.2AFA, but the expression of
193gly-M-LDH led to lower levels of subsarcolemmal ATP during chemical hypoxia. We conclude that M-LDH
regulates both the channel activity and the levels of subsarcolemmal ATP and that both mechanism
contribute to the M-LDH-mediated cytoprotection.© 2009 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
The muscle form of lactate dehydrogenase (M-LDH) is a minor
form of LDH in cardiomyocytes that physically associate with
sarcolemmal ATP-sensitive K+ (KATP) channel subunits and is a part
of sarcolemmal KATP channel protein complex [1]. KATP channels are
gated by intracellular ATP and are viewed as a link between cellular
metabolism and membrane excitability. In many different tissues,
most notably in the heart, the activation of these channels has been
shown to protect the cells against different kinds of metabolic stresses.
The mechanism of KATP channels-mediated cardioprotection is still to
be fully understood. Traditionally, it has been suggested that the
opening of sarcolemmal KATP channels shortens action membrane
potential, prevent inﬂux of Ca2+ and intracellular Ca2+ overload,
which is themain cause of cellular death inmetabolic stress [reviewed
in 2]. However, this hypothesis cannot explain how then sarcolemmal
KATP channels are protective in cells that do not generate action
membrane potential and how it comes that the changes in number of
KATP channels havemore inﬂuence on the heart susceptibility to stress
then the changes in the channel activity [2,3]. The answers to these
questions might lie in the structure of sarcolemmal KATP channel
protein complex. Structurally, the cardiac subtype of KATP channels are
heteromultimers composed of Kir6.2 subunit, an inwardly-rectifying
K+ channel core primarily responsible for K+ permeance, and SUR2A, a
regulatory subunit implicated in ligand-dependent regulation of the
channel gating [4]. More recent studies have been suggested that the+44 1382 632 597.
vić).
-NC-ND license.sarcolemmal KATP channel protein complex may physically associate
in vivowith enzymes regulating intracellular ATP levels and glycolysis;
one of those has been reported to be M-LDH [5–9]. The functional
signiﬁcance of M-LDH in cardiac myocytes is still unknown.
H9C2 cells are embryonic rat hart myocytes that have been used
with success to study cardiac sarcolemmal KATP channels [10,11].
Taking this into consideration, we have taken advantage of these cells
to study the function of M-LDH in cardiomyocytes. We report not only
that M-LDH-mediated regulation of sarcolemmal KATP channels
activity contribute to cell survival during metabolic stress, but that
ATP produced by M-LDH mediate cytoprotection independently from
the channel activity.
2. Methods
2.1. Heart H9C2 cells and viral constructs
Rat embryonic heart H9c2 cells (ECACC, Salisbury, UK) were
cultured in a tissue ﬂask (at 5% CO2) containing Dulbecco's modiﬁed
Eagle's medium supplemented with 10% fetal calf serum and 2 mM
glutamine. For electrophysiological experiments, the cells were plated
on a 35×10-mm culture dish containing 25-mm glass cover-slips. The
cells were cultured in incubators (Galaxy, oxygen control model, RS
Biotech, Irvine, UK). For the experimentsH9C2 cellswere infectedwith
adenoviruses construct containing either green ﬂuorescent protein
(GFP, gift fromC. Sunderland, University of Dundee; cells infectedwith
GFP have served as control cells in this study), Kir6.2AFA (a mutant
form of Kir6.2 where the pore GFG was mutated into AFA leading to
largely reduced K+ conductance, [12]), gly193-M-LDH (a catalytically
inactive mutant of M-LDH, [1]), luciferase and annexin VI-luciferase.
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Vector System (Stratagene) as described by the manufacturer. All of
the genes were subcloned by PCR using primers containing restrict
enzyme sites. gly193-M-LDH was already generated in our laboratory
[1] and we have subcloned this gene using the following primers:
sense, 5′-GGCAGATCTATGGCAACCCTCAAGGACCA-3′, antisense, 5′-
GCCTCGAGTTAGAACTGCAGCTCCTTCT-3′ using gly193-M-LDH as a
template. To generate Kir6.2AFA, Kir6.2 gene was subcloned using
sense, 5′-GCAGGATCCACCATGCTGTCCCGAAAGGGC-3′, antisense, 5′-
GCATCTAG ATCAGGACAAGGAATCTGGAG-3′ and the QuickChange
Site-directed mutagenesis kit (Stratagene) was used to generate
Kir6.2AFA according to themanufacturer's instructions; themutagenic
primers had the following sequences, sense, 5′-TCCAGGTGACCATTG-
CATTCGCAGGGCGCATGGTGACA-3′, antisense, 5′-TGTCACCATGCG-
CCCTGCGAATGCAATGGTCACCTGGA-3′. Luciferase gene was
subcloned using the following primers: sense, 5′-GCCTCGAGGCCAC-
CATGGAAGACGCCAAA-3′, antisense, 5′-GCGTAAGCTTACACGGCGAT-
CTTTCCGCC-3′ using pGL3-Enhancer vector (Promega) as a template.
For Annexin VI the following primers were used: sense, 5′-GCGGATC-
CATGGCCAAAATAGCACAGG-3′, antisense, 5′-CGCCTCGA GTCCGTCC-
TCTCCGCCACACAGAGC-3′ using mouse heart QUICK-Clone™ cDNA
(BD Biosciences) as a template. PCR was performed by using the
highest ﬁdelity PfuUltra™ DNA polymerase (Stratagene) under the
following condition: the PCRwas runwith a hot start for 2min at 95 °C,
followed by 25 cycles of 0.5 min at 95 °C, 0.5 min at 56 °C, and 1min at
72 °C; and a ﬁnal extension 10 min at 72 °C. The PCR products were
cloned between the Bgl II and Xho I sites of the pShuttle-CMV vector.
All of the positive clones containing DNA inserts were veriﬁed by DNA
sequencing. After construction, the shuttle vectors were linearized
with Pme I and transformed into BJ5183-AD-1 competent cells to
perform homologous recombination in Escherichia coli with these
shuttle vectors and a large adenovirus-containing plasmid following
electroporation. Recombinants were identiﬁed from single colonies,
linearised, and then transfected into HEK293 cells to produce infective
adenovirus virions. Adenoviral particles were obtained by cell
extraction after 7–10 days of transfection, and the primary virus was
further ampliﬁed by infection of AD-293 cultures. The virus titer was
determined using QuickTiter Adenovirus Titer Immunoassay Kit (Cell
Biolabs, Inc) according to manufacturer's instructions. Typical virus
titers were in the 109–1010 pfu/ml range. To infect H9C2 cells, a
solution of recombinant adenovirus was mixed with culture medium,
and cells were exposed to the virus with a multiplicity of 10 viral
particles/cell for 48 h.
2.2. Real time RT-PCR
Total RNA was extracted from heart of rat and H9C2 cells using
TRIZOL reagent (Invitrogen, Carlsbad, CA) according to the manufac-
turer's recommendations. Extracted RNA was further puriﬁed by
RNeasy Plus Mini Kit (Qiagen, Crawley, UK) according to the
manufacturer's instruction. The speciﬁc primers for rat M-LDH were
designed using Beacon Designer 3.0 software (Bio-Rad) as the
following, sense, 5′-ACAGAGTTATTGGAAGTGGTTG-3′, antisense, 5′-
GGACGCTGAGGAAGACATC-3′, 408 bp of PCR product. The speciﬁcity
of primers was tested by melting curve analysis and for their ability to
produce no signal in negative controls by dimer formation. The RTFig. 1. Kir6.2AFA and 193gly-M-LDH are efﬁcient dominant negatives of Kir6.2 and M-LDH i
currents in cellsﬁlledwith pipette solutionwith (3mM) andwithout ATP. Each point represen
membrane currents in cells ﬁlled with ATP-free pipette solution in the absence (control) and
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point represents mean±SEM (n=5–6). (D) Current–voltage relationships with correspondi
ﬁlled with pipette solution containing ATP (3mM). Each point represents mean (n=5–6). (E
ﬁlled with pipette solution containing 3 mM ATP (control) and ATP (3 mM) plus pyruvate (2
voltage relationships with corresponding original membrane currents in control cells (M-L
(3 mM) plus pyruvate (20 mM) plus NADH (20 mM). Each point represents mean±SEM (n
represents mean±SEM (n=4). (H) LDH assay with anti-Kir6.2 immunoprecipitate of memreaction was carried out with ImProm-II Reverse Transcriptase
(Promega, Madison, WI). A ﬁnal volume of 20 μl of RT reaction
containing 4 μl of 5× buffer, 3 mM MgCl2, 20 U of RNasin®
Ribonuclease inhibitor, 1 U of ImProm-II reverse transcriptase,
0.5 mM each of dATP, dCTP, dGTP, and dTTP, 0.5 μg of oligo(dT), and
1 μg of RNAwas incubated at 42 °C for 1 h and then inactivated at 70 °C
for 15 min. The produced cDNA were used as template for the
quantitative real-time PCR. A SYBR Green I system was utilized in the
reaction. The 25 μl reaction mixture contained: 12.5 μl iQ™ SYBR®
Green Supermix (2×), 7.5 nM each primers, 9 μl of ddH2O, and 2 μl of
cDNA. The thermal cycling conditions were as follows: an initial
denaturation at 95 °C for 3 min, followed by 38 cycles of 10 s of
denaturing at 95 °C, 15 s of annealing at 56 °C, and 50 s of extension at
72 °C. The real-time PCRwas performed in the samewells of a 96-well
plate in the iCycler iQ™ Multicolor Real-Time Detection System (Bio-
Rad, Hercules, CA). The data were collected following each cycle and
displayed graphically (iCycler iQ™ Real-time Detection System Soft-
ware, version 3.0A, Bio-Rad, Hercules, CA). Threshold cycle (CT) values
were determined automatically by software. The melting curve data
were collected to check the PCR speciﬁcity. The cDNA sample was
always run in duplicate and the corresponding no-RT mRNA sample
was included as a negative control [13].
2.3. Patch clamp electrophysiology
To monitor whole-cell K+ current the gigaohm seal patch-clamp
technique was applied in the whole-cell conﬁguration. For whole-
cell electrophysiology applied on H9C2 cells were superfused with
Tyrode solution (in mM: 136.5 NaCl; 5.4 KCl; 1.8 CaCl2; 0.53 MgCl2;
5.5 glucose; 5.5 HEPES–NaOH; pH 7.4). All pipettes (resistance 3–
5 MΩ), were ﬁlled with (in mM): KCl 140, MgCl2 1, EGTA–KOH 5,
HEPES–KOH 5 (pH 7.3). Depending whether open or closed KATP
channels were required, 3 μM (for ATP-free pipette solution; this
small amount of ATP was added to prevent the channel run-down)
or 3 mM (to keep KATP channels closed of ATP) of ATP was added.
When the effect of LDH substrates on whole-cell K+ current was
assessed NADH plus pyruvate (20 mM each) was added into the
pipette solution. The effect of 2,4-dinitrophenol (DNP; 10 mM) on K+
current in H9C2 cells was measured using perforated patch-clamp
electrophysiology with essentially the same pipette solution as
above just ATP was omitted and amphotericin B (Sigma, 240 μg/ml)
added. For all cells monitored, the membrane potential was
normally held at −40 mV and the currents evoked by a series of
400 ms depolarising and hyperpolarising current steps (−100 mV
to +80 mV in 20 mV steps) recorded directly to hard disk using an
Axopatch-200B ampliﬁer, Digidata-1321 interface and pClamp8
software (Axon Instruments, Inc., Forster City, CA). The capacitance
compensation was adjusted to null the additional whole-cell
capacitative current. The slow capacitance component measured
by this procedure was used as an approximation of the cell surface
area and there was no difference in cell surface area in relation to
viral infection irrespective of the gene that was introduced (in all
cases the average membrane capacitance was ∼250 pF and the
difference between control cells and any group of infected cells was
less then 7%). Currents were low pass ﬁltered at 2 kHz and sampled
at 100 μs intervals.n H9C2 cells. (A) Current–voltage relationships with corresponding original membrane
tsmean±SEM(n=5–6). (B) Current–voltage relationshipswith correspondingoriginal
presence of glybenclamide (30 μM). Each point represents mean±SEM (n=5–6). (C)
lls (Kir6.2) and cells infected with Kir6.2AFA ﬁlled with ATP-free pipette solution. Each
ng original membrane currents in control cells (Kir6.2) and cells infected with Kir6.2AFA
) Current–voltage relationships with corresponding original membrane currents in cells
0 mM) plus NADH (20 mM). Each point represents mean±SEM (n=5–6). (F) Current–
DH) and cells infected with 193gly-M-LDH ﬁlled with pipette solution containing ATP
=5–6). (G) LDH activity in control cells and cells infected with 193gly-M-LDH. Each bar
brane fraction of control cells (control) and cells infected with 193gly-M-LDH.
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The survival of H9C2 cells were assayed using Multitox-Fluor
Multiplex Cytotoxicity Assay (Promega). Brieﬂy, H9C2 cells were
plated in complete media (DMEM containing 10% FCS) in 96-well
plate, the recombinant adenovirus (GFP, Kir6.2AFA or gly193-M-LDH)was added to the wells at the multiplicity of infection of 10. After 48 h
infection, the DNPwas added to each well at the ﬁnal concentration of
10 mM. To measure cell survival 6 h later, the peptide substrate (GF-
AFC) that can be cleaved only by live cells was added to the each well.
Following 30 min-long incubation at 37 °C, plates were measured
using 1420 Multilabel Counter (Victor) plate reader, with excitation at
1382 S. Jovanović et al. / Biochimica et Biophysica Acta 1793 (2009) 1379–1386370 nm and emissions of 480 nm. The percentage of live cells was
calculated based on the intensity of ﬂuorescence according to the
manufacturer instructions.
2.5. Luciferase assay
H9C2 cellswere infectedwithGFP/luciferase (control for total ATP)
and GFP/annexin-luciferase (control for subsarcolemmal ATP) or with
ΔM-LDH/luciferase (to measure total ATP) and ΔM-LDH/annexin-
luciferase (to measure subsarcolemmal ATP) 48 h before luciferase
assay. To measure luciferase luminescence cells were mounted in 96-
well plate in buffer with the following composition (in mM): 30
HEPES, 3 ATP, 15 MgSO4, 10 DTT; pH: 7.4. Some of the cells were
untreatedwhile the otherswere treatedwith 10mMDNP. The reaction
for luciferase luminescence measurement was initiated by adding
100 μM of luciferin and the luminescence was measured on a plate
reader 1420Multibabel Counter (Victor). Luminescencewasmeasured
in the absence of DNP and after 1 h of cell incubationwith 10mMDNP.
2.6. Immunoprecipitation and lactate dehydrogenase assays
Total lactate dehydrogenase (LDH) activity was measured in H9C2
cell extracts. In brief, the cells were homogenised in buffer (TRIS
10 mM, NaH2PO4 20 mM, EDTA 1 mM, PMSF 0.1 mM, pepstatin 10 μg/
ml, leupeptin 10 μg/ml, at pH=7.8) and centrifugated at 500 g (to
remove large particles from the homogenate), the supernatant was
kept at 4 °C for 18 h and the LDH activity was measured using Roche/
Hitachi MODULAR analyzer P1800 and Cobas Roche/Hitachi kit
according to the manufacturer instructions. To obtain cellular
membrane fraction cells were homogenised in buffer I (TRIS 10 mM,
NaH2PO4 20 mM, EDTA 1 mM, PMSF 0.1 mM, pepstatin 10 μg/ml,
leupeptin 10 μg/ml, at pH=7.8) and incubated for 20 min (at 4 °C).
The osmolarity was restored with KCl, NaCl and sucrose and the
obtained mixture was centrifugated at 500 g. The supernatant was
diluted in buffer II (imidazole 30 mM, KCl 120 mM, NaCl 30 mM,
NaH2PO4 20 mM, sucrose 250 mM, pepstatin 10 μg/ml, leupeptin
10 μg/ml, at pH=6.8) and centrifugated at 7000 g, pellet removed
and supernatant centrifugated at 30000 g. The obtained pellet
contains membrane fraction. Lactate dehydrogenase activity was
determined in a reagent solution containing 0.2 M TRIS–HCl (100 ml),
6.6MNADH (1ml), 30mM sodiumpyruvate (10ml); pHwas adjusted
to 7.3 at 25 °C. LDH activity was measured using a spectrophotometer
(WPA lightwave, Jencons) set at wavelength 340 nm on pellets (20 μl)
dissolved in PBS (total volume was 100 μl) and put in reagent solution
(TRIS–HCl 1.4 ml, NADH 50 μl, sodium pyruvate 50 μl). Following
5 min incubation of the reagent solution in the spectrophotometer
pellets were added and the absorbance at 340 nmwasmeasured every
min until steady-state is reached. The reaction velocity was deter-
mined by a decrease in absorbance at 340 nm, resulting from the
oxidation of NADH indicative of LDH activity.
2.7. Statistical analysis
Data are presented as mean±S.E.M, with n representing the
number of independent experiments. Mean values were compared by
the ANOVA followed by Student's t-test or by Student's t-test alone
where appropriate using SigmaStat program (Jandel Scientiﬁc,
Chicago, Illinois). Pb0.05 was considered statistically signiﬁcant.
3. Results
3.1. The effect of Kir6.2AFA and 193gly-M-LDH on current ﬂowing
through KATP channels
Sarcolemmal KATP channels have a similar composition in the
cardiac and skeletal muscle [14]. Although H9C2 cells are known to bea cellular phenotype that is in between skeletal muscle and heart
muscle cells [15], the ﬁndings obtained with them on sarcolemmal
KATP channels and cytoprotection has been shown to be relevant for
KATP channels in the heart and cardioprotection [10,11]. This is
probably not surprisingwhen considering a similarity in KATP channels
structure/physiology between heart and skeletal muscle cells. Real
time RT-PCR has revealed that there is a slightly higher expression of
M-LDH in H9C2 cells then in adult cardiomyocytes, but no statistical
signiﬁcant difference was found (threshold cycle was 14.7±0.1 in
H9C2 cells and 15.4±0.3 in adult heart tissue, P=0.11, n=4). It is
predominant view that KATP channels, normally closed by high
intracellular ATP, have to be activated in order to protect cells against
metabolic stress (reviewed in [2]). Indeed, removal of ATP from the
pipette solution (3 mM was standard concentration of ATP in the
pipette solution) has signiﬁcantly increased whole-cell K+ current
(Fig.1A; in the presence of ATP current at 80mVwas 821±91 pAwhile
in the absence of ATP this value was 1510±264 pA, n=5–6, Pb0.01).
That this current was ﬂowing through KATP channels was further
conﬁrmed by the ﬁnding that an inhibitor of KATP channels,
glybenclamide (30 μM), has blocked the K+ current activated by
removal of intracellular ATP (Fig. 1B; the current at 80 mVwas 1602±
234 in the absence and 814±114 pA in the presence of glybenclamide,
n=5–6, Pb0.01). To study the role that the channel activity plays in
cellular responsiveness to stress we have generated adenoviral
construct containing a mutant form of the pore-forming Kir6.2
subunit, named Kir6.2AFA. Kir6.2AFA associates with SUR2A and
other KATP channel-forming proteins to form a KATP channel protein
complex but has vastly decreased ability to conduct K+ current [12].
When we have expressed Kir6.2AFA in H9C2 cells, removal of ATP did
not increase K+ current as it happened in cells expressing wild type
Kir6.2 (Fig. 1C; whole-cell current at 80 mV in virtually ATP-free
pipette solution was 1510±264 pA and 1019±108 pA for cells
expressing Kir6.2 and Kir6.2AFA, respectively, n=5–6, Pb0.01). These
ﬁndings conﬁrm that KATP channels containing Kir6.2AFA as a pore
subunit have largely impaired conductance of K+ ions. That this is an
effect speciﬁc for KATP channels was further supported by our ﬁndings
that expression of Kir6.2AFAdid not affectwhole-cell K+ currentwhen
ATP (3 mM) were present the pipette solution (Fig. 1D).
Lactate dehydrogenase (LDH) is a tetramer composed of either M
(muscle) and/or H (heart) subunits, which may be combined to form
ﬁve LDH isozymes. In the heart, all LDH isozymes are present; LDH1
(H4) is the predominant form, whereas LDH5 (M4) is present in trace
amounts [16]. It has been shown that M-LDH, but not H-LDH,
physically associate with Kir6.2 and SUR2A subunits [1]. However,
the functional signiﬁcance of this particular species of M-LDH in
myocytes is yet unknown. To address this questionwe have generated
193gly-M-LDH, a mutant form of M-LDH that is catalytically inactive
[1], into the adenovirus and expressed it in H9C2 cells. It is established
that a lactate, a product of LDH activity, acts as a KATP channel opener
and can activate the channel even in the presence of millimolar ATP
[1]. LDH substrates, pyruvate and NADH, are known to open KATP
channels in cardiomyocytes expressing wild type of M-LDH and this is
due to lactate production in the microenvironment surrounding the
channels [1]. Indeed, in cells expressing wild type of M-LDH, the
presence of pyruvate (20 mM) and NADH (20 mM) has increased
whole-cell K+ current despite intracellular presence of 3mMATP (Fig.
1E; the current at 80 mV was 821±91 pA in the absence and 1740±
221 pA in the presence of pyruvate and NADH, n=5–6, Pb0.01). In
contrast, pyruvate (20 mM) and NADH (20 mM) were not able to
increase whole-cell K+ current in cells expressing 193gly-M-LDH (Fig.
1F; the current at 80 mV was 1740±221 pA in cells expressing wild
type of M-LDH and 748±92 pA in cells expressing 193gly-M-LDH,
n=5–6, Pb0.01). Taken all together, the performed experiments
suggested that expression of 193gly-M-LDH has generated a sarco-
lemmal KATP channel protein complex that cannot be activated by
substrates of LDH, which would be in agreement with the notion that
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subunits regulates the channel behaviour. At the same time, infection
of H9C2 cells with 193gly-M-LDH did not affect total LDH activity (Fig.
1G). However, the LDH activity in Kir6.2 immunoprecipitate was
signiﬁcantly decreased in cells infected with 193gly-M-LDH when
compared to control cells (Fig. 1H). This is consistent with the ﬁndings
that M-LDH is a minor form of LDH in the heart [16] and that M-LDH
physically associate with KATP channel subunits to regulate KATP
channels activity by regulating concentration of lactate in micro-
environment surrounding the channel [1].
3.2. Regulation of KATP channels activity during chemical hypoxia
by M-LDH
2,4-dinitrophenol (DNP) is known metabolic inhibitor that was
usedwith success to inducemetabolic stress in different cell types [17].
When applied, this compound decreases intracellular ATP production
and induces chemical hypoxia, which activates KATP channels [18]. In
turn, such activation of the channels decreases a degree of cell injury
[19]. We have applied perforated patch-clamp electrophysiology to
test whether M-LDH activity regulates the opening of KATP channels
when cells are challenged with DNP. This method preserves the
intracellular milieu during the whole-cell recordings [20], which
allowed us to monitor the behaviour of KATP channels-conducted K+
current during stress under conditions of intact intracellular environ-
ment. In control H9C2 cells, DNP (10mM)has induced the activation of
KATP channels, as reﬂected by the increase in whole-cell K+ current
(Fig. 2A, D; the current at 80 mV was 610±58 pA under control
conditions and 1188±199 pA in the presence of DNP, n=5, Pb0.01),
which was not surprising considering that DNP is known as a
metabolic inhibitor that leads to the activation of sarcolemmal KATP
channels [18]. Then, we have looked whether we can detect DNP-
induced increase in K+ current when cells are infected with Kir6.2AFAFig. 2. Intact Kir6.2 and M-LDH are required for the opening of KATP channels induced b
membrane currents in control cells (A), cells infected with Kir6.2AFA (B) and cells infected
Each point represents mean±SEM (n=5). (D) Membrane current at 80 mV under conditiomutant. In these cells, DNP (10 mM) did not induce increase in K+
current (Fig. 2B, D; the current at 80mVwas 822±85pAunder control
conditions and 534±178 pA in the presence of DNP, n=5, P=0.36). It
is known that KATP channels containing Kir6.2AFA instead of Kir6.2
have largely decreased K+ conductance and the obtained results are in
agreement with the idea that DNP-induced increase in K+ current was
blocked due to Kir6.2AFA being a pore-forming subunit of the KATP
channel in H9C2 cells. It has been shown previously that M-LDH can
regulate KATP channels behaviour in a recombinant heterologues
expression system [1]. However, the role of M-LDH in regulating
sarcolemmal KATP channels in its native environment duringmetabolic
stress is yet unknown. In cells infected with catalytically inactive form
ofM-LDH,193gly-M-LDH,DNP (10mM)did not creaseK+ current (Fig.
2C, D; the current at 80 mV was 618±52 pA under control conditions
and 454±185 pA in the presence of DNP, n=5, P=0.44) suggesting
that M-LDH activity contributes to the activation of KATP channels
during metabolic stress. This would conﬁrm hypothesis that M-LDH-
produced lactate in microenvironment surrounding the channel is a
factor involved in the channel opening in stressful conditions.
3.3. Regulation of cell survival by M-LDH and KATP channels activity
during chemical hypoxia
In some studies, a failure to activate KATP channels has been
associated with the exacerbation of the outcome of the metabolic
stress [19], but in some others that was not the case [21]. Here, we
have assessedwhethermutations of Kir6.2 andM-LDHwould affect in
any way the outcome of metabolic stress with DNP. Thus, only 45.1±
1.8% (n=11) of control cells survived exposure to DNP (10 mM) (Fig.
3). When the same type of stress was imposed on cell infected with
Kir6.2AFA, survival was just slightly decreased (39.2±0.9%, n=8, Fig.
3), but the difference was statistically signiﬁcant (P=0.02). On the
other hand, cells infected with 193gly-M-LDH have been much morey chemical hypoxia. (A–C) Current–voltage relationships with corresponding original
with 193gly-M-LDH (C) under control conditions and when exposed to DNP (10 mM).
ns in A–C. Each bar represents mean±SEM (n=5).
Fig. 4. M-LDH catalytic activity, but not Kir6.2 K+ conductance, is required for
counteracting chemical hypoxia-induced decrease in subsarcolemmal ATP. Bar graphs
showing luciferase (graphs on the left) and annexin-luciferase (graphs on the right)
luminescence in cells infected with Kir6.2AFA under control conditions (normoxia) and
after treatment with 10 mM DNP (chemical hypoxia), and in cells infected with 193gly-
M-LDH under control conditions (normoxia) and after treatment with 10 mM DNP
(chemical hypoxia). Each bar represents mean±SEM (n=5). ⁎Pb0.05.
Fig. 3. Catalytic activity of M-LDH is crucial for cell survival in chemical hypoxia. A bar
graph showing a percentage of control cells, and cells infected with Kir6.2 AFA and
193gly-M-LDH that survived treatment with DNP (10 mM). Each bar represents
mean±SEM (n=6–11). ⁎Pb0.05 when compared to the control and +Pb0.05 when
Kir6.2AFA were compared with 193gly-M-LDH.
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DNP (Fig. 3, n=6). The cells expressing 193gly-M-LDH were not only
more susceptible to stress when compared to the controls (Pb0.001,
Fig. 3), but also when compared to Kir6.2AFA cells (P=0.01, Fig. 3).
Although in both, Kir6.2AFA and 193gly-M-LDH, cellular phenotypes
KATP channels were silent during stress (Fig. 2), the outcome of the
stress was much worse in cells infected with 193gly-M-LDH than in
those infected with Kir6.2AFA. A concomitant infection of cells with
Kir6.2AFA and 193gly-M-LDH did not additively decreased the cell
survival in the presence of DNP (10 mM; survival of these cells was
35.3±4.1%, n=3, P=0.14 when compared to cells infected by
193gly-M-LDH alone).
3.4. Regulation of intracellular and subsarcolemmal ATP levels by M-LDH
and KATP channels activity
The results obtained with Kir6.2AFA and 193gly-M-LDH on cell
survival has suggested that KATP channel-mediated cytoprotection
could be, at least in part, independent of the channel activity. Here,
we have elucidated the effect of DNP on total and subsarcolemmal
ATP in control cells, cells infected with Kir6.2AFA and cells infected
with 193gly-M-LDH. To be able to measure intracellular and
subsarcolemmal ATP in living cells, we have infected cells with
constructs encoding luciferase gene and annexin-luciferase, which is a
modiﬁed technique by Kennedy et al. [22]. It has been shown that this
strategy allows measurement of ATP levels in cytosol (luciferase) and
subsarcolemmal domains (annexin-luciferase). Infection with Kir6.2-
AFA per se did not affect either total or subsarcolemmal ATP levels
(total ATP: the intensity of luminescencewas 283.2±9.1 AU in control
and 302.3±6.7 AU in Kir6.2AFA cells, n=5, P=0.18; subsarcolemmal
ATP: the intensity of luminescence was 596.0±59.1 AU in control and
702.0±29.4 AU in Kir6.2AFA cells, n=5, P=0.15; Fig. 4). In the
presence of DNP, luciferase luminescencewas 71.8±2.9 in control cells
and 72.8±2.7 in Kir6.2AFA cells (n=5, P=0.80; Fig. 4). On the other
hand, annexin-luciferase luminescence in the presence of DNP
(10 mM) was 110.2±11.3 AU in control and 115.8±21.8 AU in
Kir6.2AFA cells (n=5, P=0.83, Fig. 4). The infection of cells with
193gly-M-LDH also did not affect total or subsarcolemmal ATP levels
under control conditions (total ATP: the intensity of luminescencewas
243.0±17.0 AU in control and 215.1.3±11.4 AU in 193gly-M-LDH cells,
n=5, P=0.19; subsarcolemmal ATP: the intensity of luminescence
was 541.6±86 AU in control and 529.4±38.2 AU in 193gly-M-LDH
cells, n=5, P=0.90; Fig. 4). Treatment of cells with DNP (10 mM)
induced similar decrease of total ATP in both control and 193gly-M-LDH cells (61.0±2.2 AU in control and 62.4±2.2 AU in infected cells,
n=5, P=0.67; Fig. 4). In contrast, the magnitude of DNP-induced
decrease of subsarcolemmal ATP was signiﬁcantly higher in cells
infected with 193gly-M-LDH (73.6±5.4 AU, n=5, Fig. 4) then in
control cells (92.0±5.8 AU, n=5, P=0.04; Fig. 4).
4. Discussion
In the present study, we have shown that the catalytic activity of
M-LDH is essential for cellular survival during metabolic stress. It
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regulation of sarcolemmal KATP channels activity and subsarcolemmal
ATP production.
It has been previously shown that lactate, a catalytic product of
LDH, can activate KATP channels despite high intracellular ATP. The
present study shows that the catalytic activity of M-LDH is required for
the channel opening duringmetabolic stress. It is well established that
100 μM of ATP is sufﬁcient to completely close sarcolemmal KATP
channels and this low concentration is never achieved in vivo, even
during most the severe stress [2]. As an example, we have shown in
the present study that a very high concentration of metabolic
inhibitor, DNP, has decreased luciferase luminescence, the measure
of total ATP, for ∼4 times. Taking into consideration that the
physiological concentration of intracellular ATP is 6–10 mM it would
mean that under DNP the level of ATP was ∼2 mM, which is a
concentration of ATPmore then sufﬁcient to keep the channels closed.
The obtained results support the notion that the level of ATP is not a
sole factor regulating the activity of KATP channels in vivo and suggest
a role for M-LDH as a lactate producer, a compound that can open the
channels in the presence of millimolar ATP [1].
The mechanism of cytoprotection afforded by KATP channels is a
long standing issue. The structural studies of these channels have
shown that channel subunits in vivo are physically associated with
enzymes that catalyses ATP production [5–9], including M-LDH,
which activity is particularly important under anaerobic conditions
(reviewed in 16). Such composition of sarcolemmal KATP channels
would allow a supposition that KATP channel could serve as ATP-
producing machinery. The fact that Kir6.2AFA did not affect total
ATP and subsarcolemmal ATP levels would stand against a
possibility that the changes in the channel activity alone affect the
ATP production either in subsarcolemma or anywhere else in the
cell. It seems that the channel activity per se have no bearing on
subsarcolemmal and intracellular ATP production. In contrast,
although a loss of catalytic activity of M-LDH did not affect total
intracellular ATP levels during stress, it did facilitate ATP loss in
subsarcolemmal domain. This suggests that M-LDH is an ATP
producer important for maintaining subsarcolemmal ATP during
metabolic stress. M-LDH seem to be is essential for 1) the activation
of sarcolemmal KATP channels and 2) for maintaining subsarcolem-
mal levels of ATP during stress. The fact that the inhibition of M-
LDH catalytic activity had signiﬁcantly worse outcome on cell
survival then those with the inhibition of the KATP channels
conductance alone suggests that the level of subsarcolemmal ATP
is a relevant factor in deﬁning the outcome of the metabolic stress.
As M-LDH is an integral part of the sarcolemmal KATP channel
protein complex, this implies that the KATP channels-mediated
cytoprotection involves not only regulation of membrane potential
[23,24], but also a regulation of subsarcolemmal levels of ATP. The
obtained ﬁndings would support the idea that KATP channels could
have a role in regulating cardiac bioenergetics that is yet beyond the
channel activity. At the same time, it seems that M-LDH is an
important element in cytoprotection afforded by KATP channels. A
unique property of M-LDH is that it produces a lactate that can open
the channel despite millimolar presence of ATP and, at the same
time, it produces ATP, which provide double beneﬁts for cells
exposed to metabolic stress: 1) hyperpolarisation of membrane and
decrease of Ca2+ inﬂux/Ca2+ loading and 2) production of ATP in
subsarcolemmal regions and counteracting stress-induced impair-
ments of energy-dependent membrane transport processes.
Onﬁrst sight, an increase in subsarcolemmal ATP and KATP channels
activation might look as being in contradiction. However, it is known
for years that ischemia opens sarcolemmal KATP channels before the
fall of intracellular ATP occur, suggesting that the intracellular level of
ATP is not the only factor that regulates the channel activity [25]. This is
supported by numerous evidences. As an example, in excised
membrane patches, 100 μM of ATP is sufﬁcient to abolish sarcolemmalKATP channels opening while in vivo KATP channels are activated by
hypoxia/ischaemia despite intracellular ATP being within millimolar
range [26]. Today, it is recognised that the activity of KATP channels is
controlled by a complex interaction of many intracellular factors and
signalling pathways. In addition to ATP, it has been suggested that the
activity of these channels may be regulated by other nucleotides
[27,28], intracellular pH ([29,30], lactate [1,31], cytoskeleton [32,33],
protein kinase C [34], phosphatidylinositol-4,5-bisphosphate [35], and
by the operative condition of the channel itself [36,37]. It is well
established that lactate activates KATP channels in the presence of
millimolar ATP, though the mechanism of this activation is yet
unknown [1,31]. It has been shown that intracellular acidiﬁcation
decreases sensitivity of KATP channel subunits to ATP, but there is no
evidence that this is associated with the effect of lactate. It has been
previously shown that treatment with DNP decreases pH in cardiac
cells [38] and this acidiﬁcation would certainly activate sarcolemmal
KATP channels.Wehave shown in this study that the catalytic activity of
M-LDH is required for the channels activation, which is presumably
mediated by lactate. In addition (or in connection) with lactate could
be also acidiﬁcation of the subsarcolemmal regions that would
contribute to the KATP channels opening and, thereby, to cell survival.
It has been previously shown, at both native and recombinant levels,
that the activation of KATP channels prevents DNP-induced membrane
depolarisation [23,24], which seems to decrease inﬂux of Ca2+ by
inhibiting the activation of voltage gated Ca2+ channels and prevent-
ing intracellular Ca2+ overload [23,39–41]. Thus, the activation of KATP
channels is crucial for cytoprotection, but it also seems that a little bit of
ATP produced by M-LDH also helps. As cells expressing Kir6.2AFA
(inhibits KATP channels activitywithout affect on subsarcolemmal ATP)
were more resistant then the cells expressing 193glyM-LDH (inhibits
both the KATP channels activity and slightly decrease subsarcolemmal
ATP in the presence of ATP) it seems that the M-LDH effect on
subsarcolemmal ATP levels contribute to cytoprotection afforded by
M-LDH. The fact that co-infection with Kir6.2AFA/193glyM-LDH did
not further decrease cell survival when compared to 193glyM-LDH
alone conﬁrm conclusion that Kir6.2AFA and 193glyM-LDH share the
same mechanism of increase in cellular susceptibility (which is an
inhibition of the channel activity) with 193glyM-LDH being more
deleterious due to the effect on subsarcolemmal ATP production that
Kir6.2AFA does not have.
Taken all together this study has demonstrated that M-LDH seems
to be crucial in regulating KATP channels activity, ATP production and
cellular resistance to metabolic stress. Consequently, it seems that
cytoprotection afforded by KATP channels is mediated not only by the
channel activity, but also by the production of ATP.
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